Whitehawk Therapeutics, Inc. (WHWK)
4.05
-0.15
(-3.57%)
USD |
NASDAQ |
Sep 21, 16:00
4.05
0.00 (0.00%)
After-Hours: 20:00
Whitehawk Therapeutics Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.0159 |
| September 30, 2024 | 0.0137 |
| June 30, 2024 | 0.0865 |
| March 31, 2024 | 0.0765 |
| December 31, 2023 | 0.0668 |
| September 30, 2023 | 0.0603 |
| June 30, 2023 | 0.055 |
| March 31, 2023 | 0.0502 |
| December 31, 2022 | 0.0468 |
| September 30, 2022 | 0.0442 |
| June 30, 2022 | 0.0692 |
| March 31, 2022 | 0.0509 |
| December 31, 2021 | 0.0485 |
| Date | Value |
|---|---|
| September 30, 2021 | 0.0424 |
| June 30, 2021 | 0.0003 |
| March 31, 2021 | 0.001 |
| December 31, 2020 | -1.976 |
| September 30, 2020 | 0.002 |
| June 30, 2020 | 0.0028 |
| March 31, 2020 | 0.0044 |
| December 31, 2019 | 0.0047 |
| September 30, 2019 | 0.0104 |
| June 30, 2019 | 0.0105 |
| March 31, 2019 | 0.0104 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Agenus, Inc. | -1.458 |
| Amgen, Inc. | 4.903 |
| Anika Therapeutics, Inc. | 0.1839 |
| BioCryst Pharmaceuticals, Inc. | -1.842 |
| Imunon, Inc. | 1.873 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 193.99M |
| Total Liabilities (Quarterly) | 11.07M |
| Shareholders Equity (Quarterly) | 182.92M |
| Current Ratio | 17.38 |